News

The once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes mellitus, Zydus Healthcare said.

New Delhi: Drug firm Zydus Healthcare on Sunday said it has launched generic anti-diabetic Read More

This was done through a notification by the Health Ministry on March 26. It implies that all Indian licensees are permitted to deliver at home and e-pharma is essentially nomenclature.

New Delhi: Amid the controversy over online delivery of medicines, it has emerged that the Union Health Ministry had given explicit approval for doorstep delivery of drugs through email since March.Read More

Pharmaceutical major Zydus Cadila on Thurday said it has received Drug Controller General of India (DCGI) approval for its new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASH in India.

New Delhi, Mar 5 : Pharmaceutical major Zydus Cadila on Thurday said it has received Drug Controller General of India (DCGI) approval for its new drug... Read More

At present, over 30 devices including syringes, cardiac stents and orthopaedic implants are classified as drugs (under Medical Device Rules), leaving a whole host of med technology companies “largely unregulated”.

Mumbai: All medical devices sold in the country will now be regulated as ‘Read More

The company has acquired 4 brands namely CPink, CDense, Productiv and Folinine to further strengthen its presence in women's health portfolio.

New Delhi: Homegrown pharma firm Cipla on Saturday announced the acquisition of nutrition products portfolio from Wanbury Ltd. The company has acquired 4 brands namely Read More

Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with the health and family welfare ministry on Thursday issuing a notification to this effect.

ew Delhi: Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with ... Read More

The business comprises of a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines, which would transfer to Dr. Reddy’s along with related sales and marketing teams

Hyderabad, India February 12, 2020— Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) today announced that it has entered into a definitive agreement with Read More

The domestic pharmaceutical market is abuzz with news of over 15-20 companies launching generic versions of the widely-prescribed anti-diabetic drug Vildagliptin, with its price expected to crash by half.

MUMBAI: There is some good news for the over 72 million diabetics in India, with a cheaper version of a blockbuster drug hitting the market on December 10. The domestic pharm... Read More

Reliance Life Sciences, the biotech subsidiary of Reliance Group, plans to start pathology labs across India through partnerships with local entrepreneurs, according to a news report.

Mumbai: Reliance Group’s proposed entry into the diagnostic business threatens existing diagnostic players who fear the entry of India’s biggest corporate group with deep pockets will s... Read More

The health ministry has proposed to notify all medical devices from December 1, expanding the span of regulation to ensure safety and efficacy of a variety of such products used for diagnosis.

EW DELHI: The health ministry has proposed to notify all medical devices from December ... Read More

In a meeting held earlier this month with Niti Aayog, DoP also suggested that trade margin on all formulations and dosages be capped at 100%.

NEW DELHI: In a bid to curb profiteering, the Department of Pharmaceuticals (DoP) has proposed a few options to rationalise the Read More

The government’s Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) campaign should ideally be a runaway success.

By Dr. Vikram A Munshi
Founder at WhiteSpace Consulting & Capability Building

With the Indian healthcare industry seeing a robust growth trajectory, where the average per capita spending on healthcare in a year is just Rs 1,112, the government’s Read More

With one of the relatively newer but important anti-diabetic drugs, Vildagliptin manufactured by Novartis, losing patent protection in December, dozens of companies are readying plans to launch the generic version to get a slice of the action in the growing Rs 13,000-crore diabetes therapy. The cost of therapy is expected to reduce by over 50%.
MUMBAI: There is some good news around the corner for the over 72 million diabetics in India, as cheaper versions of a blockbuster drug are expe... Read More

He said Jan Aushadhi stores are opened with an aim of providing quality and affordable medicines to the poor.

The price of 1032 essential medicines have been capped by the government to help provide poor medicines at cheaper rates, the Rajya Sabha was informed Friday. 

Min... Read More

Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family.

Mumbai: Private equity group Advent International has emerged as the sole contender for acquiring Mumbai-based biopharma company Bharat Serums and Vaccines (BSV) with a bid worth Rs 3,600 crore ($520 million) after rival contenders backed out of the two-year-long sale process,... Read More

he report, tiltled 'Indian Pharmaceutical Industry: The Way Forward - Vision 2030', is based on a research collaboration with McKinsey & Co and inputs from the IPA members and industry leaders, IPA said in a statement. 

NEW DELHI: The Indian pharmaceutical industry is aspiring to touch USD 120-130 billion by 2030 from the current USD 38 billion, industry bod... Read More

Jeetendra Belani, a pharmaceutical exporter, was arrested in Prague in Czech Republic on June 3 for allegedly supplying in US ‘controlled’ medicines that can be sold only under prescription.

Nagpur: Jeetendra Belani, a pharmaceutical exporter, was arrested in Read More